Global extracorporeal membrane oxygenation machines market was valued at USD 202.6 millions in 2020. It is expected to grow at a compound annual rate (CAGR of 5.1%) between 2021 and 2028. Extracorporeal membrane oxygenation market (ECMO), is driven by the rising incidence of cardiovascular disease and respiratory failure. According to the Centers for Disease Control and Prevention, a person dies from cardiovascular disease every 37 seconds in the United States. In 2018, the number one cause of death in the U.S. was chronic obstructive lung disease (COPD). The market is growing due to the increasing number of hospitals that offer ECMO services, and the increase in awareness programs. According to the Federal Agency of Health Research and Quality in 2014, there were 6890 ECMO operations performed in the U.S. Since then, ECMO machines have been adopted in more hospitals.
Extracorporeal Life Support Organization, (ELSO) reports that 264 hospitals offered ECMO services in 2019, up from 108 in 2008. ECMO devices can be used to treat serious COVID-19 cases. In 2020, however, the market for other uses of these devices (e.g. heart procedures) declined sharply. The market is also growing due to increasing awareness of ECMO procedures, and technological advancements. Many government agencies are working to raise awareness about ECMO Procedures. Initiatives like the Global Initiative for Chronic Obstructive Leng Disease (GOLD), which aims to raise awareness about COPD and its treatment, including the use of ECMO devices, are a part of the Global Initiative for Chronic Obstructive Lung Disease.
The increasing use of ECMO machines is also driving technological innovation in these systems. These include oxygenators, hollow pumps, heparin-coated catheters, and other applications for surgeries. The ECMO machines that have been recently developed are also smaller, making them more portable and easier to use. ECMO machines can also be transported by using portable adaptors or compact circuits.
Pandemic Impact |
Outlook after COVID |
ECMO machines are a lifesaver to severe COVID-19 sufferers. However, strict regulations limit their use. |
From 2021 to 2028, the demand for ECMO devices is expected to rise at a rate of more than 5%. Major hospitals stocking up on ECMO devices in case of pandemics is likely to drive the growth. |
During the pandemic, the overall market experienced a 70% drop in its value. |
Multiple studies have shown that patients with COVID-19 will likely experience a decline in immunity and long-term symptoms, which could lead to an increase in organ failure and increased demand for ECMO devices. |
The increasing number of people over 65 and the rising incidence of coronary disease are driving the growth of ECMO machines. The leading cause of death in the world is coronary heart disease, which is strongly linked to age. The United Nations projects that the number of people over 80 years old will rise to 426 million by 2050, from 143 million globally in 2019. The market may be limited by complications such as bleeding, technical failures, infections and high costs of treatment.
The oxygenator segment held 34.1% of the market share in 2020, and it is expected to continue growing at a rapid pace during the forecast period. The high price and the acute exchange rate for an alternative system is what explains the large market share of oxygenator. Mechanical failure, pump head and acute oxygenator complications are the main causes of low exchange rates for oxygenator.
Due to its high price and widespread usage, the pumps segment held a significant market share in 2020. Pumps in ECMO machines are used to pump blood from a patient into artificial lungs, which then send it back to the patient. This segment has seen a lot of growth due to the large use of pumps in ECMO procedures. There are many types of pumps available, including impeller, roller and centrifugal. These pumps can be used for various ECMO procedures depending on their needs.
In 2020, the veno-arterial segment held 41.8% of the market and is expected grow at a healthy CAGR over the forecast period. Its high use in treating cardiac arrest patients and assisting with algorithm-based strategies to restore blood flow is what accounts for the largest segment.
In 2020, the veno-venous segment accounted for a large share and is expected to continue growing at a rapid pace during the forecast period. The veno-venous ECMO circuit (VV ECMO), serves the primary purpose of facilitating the exchange of oxygen and carbon dioxide. It is therefore a very important application for cases in which lung support is required. This segment is driven by the increasing prevalence of chronic obstructive lung disease. The WHO estimates that there were 251,000,000 cases of COPD worldwide in 2016, and this number will continue to rise over the forecast period.
In 2020, the respiratory segment held 43.9% of the market share. This segment is driven by the rising prevalence of respiratory diseases and increased awareness of ECMO procedures. The ELSO published statistics showing that more than 2,600 people with respiratory diseases in the U.S. received ECMO treatment in 2015.
Due to increasing cardiac surgery rates and increased awareness about ECMO machines in heart surgery, the segment of cardiac surgery accounted for a significant market share in 2020. According to the American Heart Association in 2016, approximately one in three deaths in America was due to cardiovascular disease. The segment will be driven by the rising cost of ECMO procedures, particularly in cardiac surgery. A study found that the direct medical costs for cardiovascular diseases will reach USD 749 millions by 2035.
In 2020, the adult segment was responsible for the largest percentage of 59.0% and it is expected to grow at a faster rate over the forecast period. The global burden of respiratory and cardiac diseases is rising in adults due to increased consumption of alcohol, tobacco and smoking. The Extracorporeal Life Support Organization released a report that showed that there were approximately 7,850 people with cardiac diseases in January 2016.
The market share held by the pediatric segment was substantial and will continue to grow during the forecast period. One of the main drivers for this segment is the increasing number of children suffering from various pulmonary diseases. Extracorporeal Life Support Organization estimates that around 8.102 children were affected by cardiac disease in January 2016. These children required ECMO therapy.
North America held a 39.8% market share in 2020, thanks to major players and increasing product launches. This market has grown due to government support for high quality healthcare, high purchasing power parity and increasing incidence of diseases such as chronic obstructive lung disease in Canada and the U.S. Hospital admissions have increased due to the availability of high-quality healthcare facilities and favorable reimbursement policies. This will in turn increase the region's usage.
Asia Pacific will experience the fastest growth over the forecast period. The growth of this market is fueled by a rise in healthcare spending by both the government and private entities to improve healthcare facilities. Market growth will also be supported by rising economic development in countries like Japan, India and China.
Technology collaboration is a key focus for major players. Terumo Cardiovascular Systems Corporation, for instance, launched the CAPIOX FX advanced oxygenator in February 2016. The advanced features of this device include a 3,000ml reservoir, increased blood flow rate, and improved flow dynamics. These launches are more efficient and help to support market growth. The market leader in extracorporeal membrane oxygenation machines is:
Medtronic plc
Sorin Group
Terumo Cardiovascular Systems Corporation
MAQUET Holding B.V. & Co. KG
Medos Medizintechnik AG
Nipro Medical Corporation
Microport Scientific Corporation
Up Market Research published a new report titled “Extracorporeal Membrane Oxygenation Machine Market research report which is segmented by Component (Pumps, Oxygenator), By Players/Companies MAQUET Holding BV & Co KG, Terumo Cardiovascular Systems Corporation, Medtronic plc, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Extracorporeal Membrane Oxygenation Machine Market Research Report |
By Component | Pumps, Oxygenator |
By Companies | MAQUET Holding BV & Co KG, Terumo Cardiovascular Systems Corporation, Medtronic plc, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 220 |
Number of Tables & Figures | 154 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Component (Pumps, Oxygenator).
Extracorporeal Membrane Oxygenation Machine Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Extracorporeal Membrane Oxygenation Machine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Extracorporeal Membrane Oxygenation Machine Market Report:
Some other reports from this category!